Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gata3
|
ENSMUSG00000015619.10 | GATA binding protein 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_9878560_9878711 | Gata3 | 35 | 0.946280 | 0.84 | 3.5e-02 | Click! |
chr2_9879639_9879800 | Gata3 | 1119 | 0.299755 | -0.64 | 1.7e-01 | Click! |
chr2_9879031_9879492 | Gata3 | 661 | 0.515775 | 0.64 | 1.7e-01 | Click! |
chr2_9878300_9878451 | Gata3 | 225 | 0.840371 | 0.11 | 8.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_125524109_125525122 | 11.10 |
Tmem132b |
transmembrane protein 132B |
7159 |
0.16 |
chr17_28502859_28503010 | 9.30 |
Fkbp5 |
FK506 binding protein 5 |
4472 |
0.09 |
chr8_36265077_36265268 | 6.89 |
Lonrf1 |
LON peptidase N-terminal domain and ring finger 1 |
15656 |
0.2 |
chr12_104343910_104344587 | 6.21 |
Serpina3k |
serine (or cysteine) peptidase inhibitor, clade A, member 3K |
5762 |
0.12 |
chr14_7870473_7870795 | 5.43 |
Flnb |
filamin, beta |
14107 |
0.18 |
chr19_44399005_44399361 | 5.25 |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
7507 |
0.15 |
chr4_84540692_84540849 | 5.08 |
Bnc2 |
basonuclin 2 |
5520 |
0.32 |
chr19_44400352_44400581 | 4.97 |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
6224 |
0.15 |
chr2_26588564_26589214 | 4.87 |
Egfl7 |
EGF-like domain 7 |
346 |
0.71 |
chr9_106231818_106232229 | 4.84 |
Alas1 |
aminolevulinic acid synthase 1 |
5061 |
0.11 |
chr7_143754683_143755199 | 4.78 |
Osbpl5 |
oxysterol binding protein-like 5 |
2044 |
0.2 |
chr9_42137204_42137355 | 4.46 |
Gm39321 |
predicted gene, 39321 |
4714 |
0.22 |
chr9_44096490_44096809 | 4.25 |
Usp2 |
ubiquitin specific peptidase 2 |
3975 |
0.08 |
chr3_97635501_97635936 | 4.20 |
Fmo5 |
flavin containing monooxygenase 5 |
6835 |
0.14 |
chr3_138363372_138363558 | 4.04 |
Adh6-ps1 |
alcohol dehydrogenase 6 (class V), pseudogene 1 |
10656 |
0.12 |
chr19_37455329_37455494 | 4.03 |
Gm23026 |
predicted gene, 23026 |
8335 |
0.12 |
chr2_31479250_31479512 | 4.02 |
Ass1 |
argininosuccinate synthetase 1 |
9174 |
0.19 |
chr10_111314954_111315105 | 3.95 |
Bbs10 |
Bardet-Biedl syndrome 10 (human) |
16350 |
0.18 |
chr16_25221689_25221840 | 3.93 |
Tprg |
transformation related protein 63 regulated |
65053 |
0.14 |
chr7_63922331_63923024 | 3.89 |
Klf13 |
Kruppel-like factor 13 |
2193 |
0.22 |
chr9_106238560_106238771 | 3.86 |
Alas1 |
aminolevulinic acid synthase 1 |
65 |
0.95 |
chr6_144709069_144709350 | 3.80 |
Sox5os4 |
SRY (sex determining region Y)-box 5, opposite strand 4 |
11702 |
0.16 |
chr1_21324523_21325070 | 3.64 |
Gm21909 |
predicted gene, 21909 |
8476 |
0.1 |
chr11_5905000_5905191 | 3.54 |
Gck |
glucokinase |
3008 |
0.15 |
chr11_61355295_61355921 | 3.51 |
Slc47a1 |
solute carrier family 47, member 1 |
10044 |
0.13 |
chr19_44395706_44395857 | 3.50 |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
10909 |
0.14 |
chr8_93266650_93266871 | 3.45 |
Ces1f |
carboxylesterase 1F |
518 |
0.73 |
chr6_137784539_137784690 | 3.42 |
Dera |
deoxyribose-phosphate aldolase (putative) |
3791 |
0.29 |
chr11_60196823_60197490 | 3.39 |
Mir6921 |
microRNA 6921 |
3461 |
0.14 |
chr4_108136157_108136308 | 3.25 |
Scp2 |
sterol carrier protein 2, liver |
8762 |
0.15 |
chr13_45623869_45624201 | 3.24 |
Gmpr |
guanosine monophosphate reductase |
77882 |
0.1 |
chr10_80577672_80578424 | 3.22 |
Klf16 |
Kruppel-like factor 16 |
727 |
0.41 |
chr2_155066050_155066313 | 3.18 |
Gm45609 |
predicted gene 45609 |
8000 |
0.14 |
chr3_51247658_51247809 | 3.17 |
Noct |
nocturnin |
4325 |
0.15 |
chr5_151246769_151246920 | 3.17 |
5430435K18Rik |
RIKEN cDNA 5430435K18 gene |
5461 |
0.2 |
chr2_160362942_160363707 | 3.15 |
Mafb |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian) |
3741 |
0.3 |
chr4_132415601_132415752 | 3.12 |
Phactr4 |
phosphatase and actin regulator 4 |
6765 |
0.1 |
chr5_17849054_17849205 | 3.12 |
Cd36 |
CD36 molecule |
600 |
0.84 |
chr1_92112718_92112883 | 3.12 |
Hdac4 |
histone deacetylase 4 |
531 |
0.84 |
chr1_67213641_67214357 | 3.09 |
Gm15668 |
predicted gene 15668 |
35201 |
0.17 |
chr2_31484723_31485077 | 3.09 |
Ass1 |
argininosuccinate synthetase 1 |
12872 |
0.18 |
chr11_33931902_33932233 | 3.08 |
Kcnmb1 |
potassium large conductance calcium-activated channel, subfamily M, beta member 1 |
30946 |
0.19 |
chr3_51226339_51227024 | 3.08 |
Noct |
nocturnin |
2211 |
0.23 |
chr13_102593887_102594038 | 3.08 |
Gm29927 |
predicted gene, 29927 |
3677 |
0.27 |
chr3_94696435_94696690 | 3.07 |
Selenbp2 |
selenium binding protein 2 |
2903 |
0.15 |
chr2_31478552_31479205 | 3.07 |
Ass1 |
argininosuccinate synthetase 1 |
8671 |
0.19 |
chr15_3432918_3433085 | 3.07 |
Ghr |
growth hormone receptor |
38643 |
0.2 |
chr9_48984872_48985421 | 3.05 |
Usp28 |
ubiquitin specific peptidase 28 |
229 |
0.92 |
chr7_113961588_113961904 | 3.03 |
Gm45615 |
predicted gene 45615 |
125152 |
0.05 |
chr19_44400900_44401269 | 3.03 |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
5606 |
0.16 |
chr3_145924039_145924997 | 3.00 |
Bcl10 |
B cell leukemia/lymphoma 10 |
161 |
0.95 |
chr8_105087174_105087570 | 2.99 |
Ces3b |
carboxylesterase 3B |
1247 |
0.3 |
chr8_93179442_93179779 | 2.96 |
Ces1d |
carboxylesterase 1D |
4321 |
0.16 |
chr5_44151689_44151902 | 2.93 |
Gm42427 |
predicted gene 42427 |
13815 |
0.1 |
chr17_28519046_28519420 | 2.93 |
Gm49861 |
predicted gene, 49861 |
775 |
0.35 |
chr3_97645418_97646002 | 2.92 |
Prkab2 |
protein kinase, AMP-activated, beta 2 non-catalytic subunit |
12483 |
0.13 |
chr16_18339885_18340233 | 2.92 |
Tango2 |
transport and golgi organization 2 |
981 |
0.34 |
chr8_93181874_93182111 | 2.90 |
Ces1d |
carboxylesterase 1D |
6703 |
0.14 |
chr3_97636991_97637334 | 2.90 |
Fmo5 |
flavin containing monooxygenase 5 |
8279 |
0.14 |
chr12_104082595_104082890 | 2.87 |
Serpina4-ps1 |
serine (or cysteine) peptidase inhibitor, clade A, member 4, pseudogene 1 |
2093 |
0.18 |
chr2_58773911_58774203 | 2.86 |
Upp2 |
uridine phosphorylase 2 |
8732 |
0.21 |
chr5_120481198_120481714 | 2.86 |
Gm15690 |
predicted gene 15690 |
553 |
0.54 |
chr12_104089964_104090240 | 2.86 |
Serpina4-ps1 |
serine (or cysteine) peptidase inhibitor, clade A, member 4, pseudogene 1 |
9453 |
0.1 |
chr12_72625503_72625735 | 2.84 |
Gm4756 |
predicted gene 4756 |
3218 |
0.22 |
chr5_149616281_149616432 | 2.84 |
Hsph1 |
heat shock 105kDa/110kDa protein 1 |
2817 |
0.21 |
chr11_5904597_5904748 | 2.82 |
Gck |
glucokinase |
2585 |
0.17 |
chr14_120830490_120830770 | 2.82 |
Gm9391 |
predicted gene 9391 |
3472 |
0.2 |
chr8_84760806_84761030 | 2.81 |
Nfix |
nuclear factor I/X |
12478 |
0.1 |
chr7_98352590_98353259 | 2.81 |
Tsku |
tsukushi, small leucine rich proteoglycan |
7155 |
0.18 |
chr10_69263911_69264128 | 2.81 |
Rhobtb1 |
Rho-related BTB domain containing 1 |
1618 |
0.39 |
chr15_99033646_99034208 | 2.76 |
Tuba1c |
tubulin, alpha 1C |
3606 |
0.11 |
chr15_59024907_59025221 | 2.75 |
Mtss1 |
MTSS I-BAR domain containing 1 |
15532 |
0.19 |
chr11_54355641_54355819 | 2.74 |
Gm12224 |
predicted gene 12224 |
2251 |
0.21 |
chr16_30968839_30969241 | 2.73 |
Gm15742 |
predicted gene 15742 |
4478 |
0.21 |
chr1_67215139_67215608 | 2.73 |
Gm15668 |
predicted gene 15668 |
33827 |
0.17 |
chr9_107770327_107770857 | 2.73 |
Rbm5 |
RNA binding motif protein 5 |
97 |
0.94 |
chr8_93193292_93193577 | 2.72 |
Gm45909 |
predicted gene 45909 |
2076 |
0.23 |
chr2_181461827_181461978 | 2.71 |
Zbtb46 |
zinc finger and BTB domain containing 46 |
2476 |
0.17 |
chr6_119397559_119397710 | 2.70 |
Adipor2 |
adiponectin receptor 2 |
7386 |
0.22 |
chr12_104083020_104083260 | 2.68 |
Serpina4-ps1 |
serine (or cysteine) peptidase inhibitor, clade A, member 4, pseudogene 1 |
2491 |
0.16 |
chr7_73617891_73618724 | 2.67 |
Gm44738 |
predicted gene 44738 |
9128 |
0.1 |
chr3_52289802_52290007 | 2.65 |
Gm38034 |
predicted gene, 38034 |
7663 |
0.15 |
chr6_129528344_129528723 | 2.65 |
Gabarapl1 |
gamma-aminobutyric acid (GABA) A receptor-associated protein-like 1 |
4627 |
0.09 |
chr10_111484318_111484665 | 2.64 |
Gm25117 |
predicted gene, 25117 |
2998 |
0.18 |
chr8_35388227_35388603 | 2.63 |
Ppp1r3b |
protein phosphatase 1, regulatory subunit 3B |
11755 |
0.15 |
chr19_44398143_44398357 | 2.63 |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
8440 |
0.15 |
chr11_5900289_5900501 | 2.63 |
Myl7 |
myosin, light polypeptide 7, regulatory |
1613 |
0.22 |
chr8_85519627_85519778 | 2.62 |
Gpt2 |
glutamic pyruvate transaminase (alanine aminotransferase) 2 |
293 |
0.89 |
chr14_103345623_103346410 | 2.62 |
Mycbp2 |
MYC binding protein 2, E3 ubiquitin protein ligase |
402 |
0.87 |
chr1_67185796_67186060 | 2.61 |
Cps1 |
carbamoyl-phosphate synthetase 1 |
62902 |
0.11 |
chr19_44414752_44414914 | 2.60 |
Gm50337 |
predicted gene, 50337 |
4777 |
0.16 |
chr1_21260733_21261242 | 2.60 |
Gsta3 |
glutathione S-transferase, alpha 3 |
7466 |
0.11 |
chr3_97651369_97651605 | 2.58 |
Prkab2 |
protein kinase, AMP-activated, beta 2 non-catalytic subunit |
6706 |
0.14 |
chr1_67168769_67168980 | 2.58 |
Cps1 |
carbamoyl-phosphate synthetase 1 |
45848 |
0.15 |
chr8_64849910_64850714 | 2.58 |
Klhl2 |
kelch-like 2, Mayven |
295 |
0.88 |
chr13_95639844_95639995 | 2.57 |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
21179 |
0.13 |
chr8_35219364_35219515 | 2.56 |
Gm34474 |
predicted gene, 34474 |
801 |
0.55 |
chr1_21246529_21246960 | 2.56 |
Gsta3 |
glutathione S-transferase, alpha 3 |
6115 |
0.12 |
chr5_124425319_124425853 | 2.55 |
Sbno1 |
strawberry notch 1 |
2 |
0.38 |
chr1_171260026_171260323 | 2.55 |
Adamts4 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 4 |
8058 |
0.07 |
chr14_121720038_121720281 | 2.55 |
Dock9 |
dedicator of cytokinesis 9 |
18702 |
0.23 |
chr8_34164335_34164526 | 2.54 |
Mir6395 |
microRNA 6395 |
2282 |
0.18 |
chr3_94398218_94398392 | 2.54 |
Lingo4 |
leucine rich repeat and Ig domain containing 4 |
212 |
0.81 |
chr7_81707314_81707700 | 2.53 |
Homer2 |
homer scaffolding protein 2 |
20 |
0.97 |
chr9_9565147_9565311 | 2.52 |
Gm47334 |
predicted gene, 47334 |
1142 |
0.57 |
chr10_81412487_81412833 | 2.51 |
Gm16104 |
predicted gene 16104 |
3085 |
0.08 |
chr9_122138047_122138206 | 2.51 |
Gm47121 |
predicted gene, 47121 |
4323 |
0.14 |
chr10_87905188_87905714 | 2.50 |
Igf1os |
insulin-like growth factor 1, opposite strand |
42070 |
0.13 |
chr9_108089036_108089891 | 2.49 |
Apeh |
acylpeptide hydrolase |
943 |
0.28 |
chr15_88858344_88858998 | 2.48 |
Pim3 |
proviral integration site 3 |
3515 |
0.17 |
chr8_90953330_90953683 | 2.47 |
Chd9 |
chromodomain helicase DNA binding protein 9 |
1452 |
0.39 |
chr11_16856758_16857153 | 2.47 |
Egfr |
epidermal growth factor receptor |
21195 |
0.18 |
chr14_7871226_7871377 | 2.46 |
Flnb |
filamin, beta |
13440 |
0.19 |
chr19_41482156_41482948 | 2.46 |
Lcor |
ligand dependent nuclear receptor corepressor |
85 |
0.98 |
chr1_4809987_4810139 | 2.46 |
Lypla1 |
lysophospholipase 1 |
1826 |
0.21 |
chr1_195013221_195013372 | 2.45 |
9630010A21Rik |
RIKEN cDNA 9630010A21 gene |
450 |
0.65 |
chr8_93183570_93183871 | 2.45 |
Gm45909 |
predicted gene 45909 |
7638 |
0.14 |
chr5_125515518_125515904 | 2.45 |
Aacs |
acetoacetyl-CoA synthetase |
468 |
0.77 |
chr5_146901911_146902074 | 2.44 |
Gtf3a |
general transcription factor III A |
46665 |
0.09 |
chr8_94399880_94400067 | 2.44 |
Ap3s1-ps2 |
adaptor-related protein complex 3, sigma 1 subunit, pseudogene 2 |
5238 |
0.11 |
chr2_31513768_31514291 | 2.44 |
Ass1 |
argininosuccinate synthetase 1 |
4461 |
0.2 |
chr3_129451172_129451350 | 2.42 |
Rpl7a-ps7 |
ribosomal protein L7A, pseudogene 7 |
10711 |
0.17 |
chr15_88866027_88866463 | 2.42 |
Pim3 |
proviral integration site 3 |
1325 |
0.34 |
chr2_148037591_148038164 | 2.41 |
9030622O22Rik |
RIKEN cDNA 9030622O22 gene |
393 |
0.84 |
chr3_135510262_135510447 | 2.41 |
Manba |
mannosidase, beta A, lysosomal |
6796 |
0.13 |
chr18_33433732_33433917 | 2.41 |
Nrep |
neuronal regeneration related protein |
29611 |
0.17 |
chr4_63251381_63251799 | 2.40 |
Mir455 |
microRNA 455 |
5261 |
0.19 |
chr3_18176973_18177124 | 2.38 |
Gm23686 |
predicted gene, 23686 |
577 |
0.81 |
chr6_85811078_85811251 | 2.38 |
Nat8f6 |
N-acetyltransferase 8 (GCN5-related) family member 6 |
1301 |
0.25 |
chr7_97424594_97424745 | 2.38 |
Thrsp |
thyroid hormone responsive |
6939 |
0.13 |
chr7_26841841_26842035 | 2.37 |
Cyp2a5 |
cytochrome P450, family 2, subfamily a, polypeptide 5 |
994 |
0.51 |
chr6_55173061_55173603 | 2.36 |
Inmt |
indolethylamine N-methyltransferase |
1682 |
0.33 |
chr9_78192592_78192962 | 2.35 |
Gsta4 |
glutathione S-transferase, alpha 4 |
830 |
0.46 |
chr9_122173247_122173478 | 2.35 |
Snrk |
SNF related kinase |
6618 |
0.14 |
chr8_109997497_109997880 | 2.33 |
Tat |
tyrosine aminotransferase |
7182 |
0.12 |
chr17_25866831_25867238 | 2.33 |
Mcrip2 |
MAPK regulated corepressor interacting protein 2 |
802 |
0.3 |
chr10_53353543_53353887 | 2.33 |
Cep85l |
centrosomal protein 85-like |
3892 |
0.15 |
chr2_134491717_134491883 | 2.32 |
Hao1 |
hydroxyacid oxidase 1, liver |
62507 |
0.15 |
chr11_16841273_16841607 | 2.31 |
Egfros |
epidermal growth factor receptor, opposite strand |
10738 |
0.21 |
chr7_19804504_19804748 | 2.31 |
Gm16175 |
predicted gene 16175 |
4983 |
0.08 |
chr15_88832888_88833102 | 2.31 |
Gm23144 |
predicted gene, 23144 |
2305 |
0.21 |
chr3_94705046_94705225 | 2.31 |
Selenbp2 |
selenium binding protein 2 |
11476 |
0.11 |
chr11_60206288_60206935 | 2.30 |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
499 |
0.68 |
chr14_34337728_34337928 | 2.30 |
Glud1 |
glutamate dehydrogenase 1 |
2456 |
0.16 |
chr7_98358819_98359055 | 2.30 |
Tsku |
tsukushi, small leucine rich proteoglycan |
1142 |
0.47 |
chr2_31519719_31520357 | 2.30 |
Ass1 |
argininosuccinate synthetase 1 |
1548 |
0.36 |
chr9_74881023_74881569 | 2.29 |
Onecut1 |
one cut domain, family member 1 |
14812 |
0.15 |
chr18_33436230_33436484 | 2.29 |
Nrep |
neuronal regeneration related protein |
27078 |
0.18 |
chr2_134727020_134727171 | 2.28 |
Gm14037 |
predicted gene 14037 |
4012 |
0.25 |
chr10_87865511_87865999 | 2.27 |
Igf1os |
insulin-like growth factor 1, opposite strand |
2374 |
0.3 |
chr10_40519986_40520137 | 2.27 |
Gm18671 |
predicted gene, 18671 |
28831 |
0.16 |
chr2_31513022_31513372 | 2.26 |
Ass1 |
argininosuccinate synthetase 1 |
5293 |
0.19 |
chr6_90591147_90591298 | 2.26 |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
1872 |
0.26 |
chr9_106233543_106233694 | 2.26 |
Alas1 |
aminolevulinic acid synthase 1 |
3466 |
0.12 |
chr6_108092522_108092680 | 2.26 |
Setmar |
SET domain without mariner transposase fusion |
27539 |
0.18 |
chr11_16852969_16853170 | 2.25 |
Egfros |
epidermal growth factor receptor, opposite strand |
22367 |
0.17 |
chr13_101681950_101682101 | 2.25 |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
10318 |
0.23 |
chr6_90469663_90469814 | 2.24 |
Klf15 |
Kruppel-like factor 15 |
2620 |
0.15 |
chr14_30929998_30930386 | 2.23 |
Itih3 |
inter-alpha trypsin inhibitor, heavy chain 3 |
6432 |
0.11 |
chr6_115635892_115636260 | 2.23 |
Raf1 |
v-raf-leukemia viral oncogene 1 |
1455 |
0.27 |
chr7_30960896_30961408 | 2.22 |
Gm4673 |
predicted gene 4673 |
3743 |
0.08 |
chr8_104809263_104809415 | 2.21 |
4932416K20Rik |
RIKEN cDNA 4932416K20 gene |
12856 |
0.09 |
chr9_103209178_103209657 | 2.21 |
Trf |
transferrin |
2589 |
0.24 |
chr11_120815283_120815743 | 2.21 |
Fasn |
fatty acid synthase |
58 |
0.94 |
chr8_94399242_94399642 | 2.21 |
Ap3s1-ps2 |
adaptor-related protein complex 3, sigma 1 subunit, pseudogene 2 |
5769 |
0.11 |
chr9_48729921_48730093 | 2.20 |
Zbtb16 |
zinc finger and BTB domain containing 16 |
105938 |
0.06 |
chr2_130931663_130931814 | 2.20 |
Atrn |
attractin |
24807 |
0.11 |
chr2_104583567_104583832 | 2.20 |
Gm13885 |
predicted gene 13885 |
82 |
0.95 |
chr6_122128951_122129135 | 2.19 |
Gm10319 |
predicted pseudogene 10319 |
7585 |
0.2 |
chr3_97225695_97225846 | 2.19 |
Bcl9 |
B cell CLL/lymphoma 9 |
1561 |
0.36 |
chr9_122849642_122849881 | 2.19 |
Gm47140 |
predicted gene, 47140 |
1343 |
0.27 |
chr8_109996628_109997116 | 2.19 |
Tat |
tyrosine aminotransferase |
6366 |
0.13 |
chr3_51253047_51253213 | 2.18 |
Elf2 |
E74-like factor 2 |
7111 |
0.13 |
chr15_58995280_58995901 | 2.18 |
4930544F09Rik |
RIKEN cDNA 4930544F09 gene |
11454 |
0.17 |
chr10_87880307_87880601 | 2.17 |
Igf1os |
insulin-like growth factor 1, opposite strand |
17073 |
0.18 |
chr14_8267542_8267726 | 2.17 |
Acox2 |
acyl-Coenzyme A oxidase 2, branched chain |
8281 |
0.2 |
chr2_173659583_173659933 | 2.16 |
Rab22a |
RAB22A, member RAS oncogene family |
2 |
0.61 |
chr8_109865561_109865712 | 2.15 |
Ap1g1 |
adaptor protein complex AP-1, gamma 1 subunit |
2528 |
0.16 |
chr11_7815805_7815978 | 2.15 |
Gm27393 |
predicted gene, 27393 |
70614 |
0.13 |
chr2_71607608_71607769 | 2.14 |
Dlx2 |
distal-less homeobox 2 |
60934 |
0.09 |
chr12_32769180_32769331 | 2.14 |
Nampt |
nicotinamide phosphoribosyltransferase |
50290 |
0.12 |
chr12_16588332_16588597 | 2.14 |
Lpin1 |
lipin 1 |
1256 |
0.53 |
chr11_6012474_6012958 | 2.13 |
Camk2b |
calcium/calmodulin-dependent protein kinase II, beta |
12268 |
0.17 |
chr9_21425419_21426009 | 2.12 |
Dnm2 |
dynamin 2 |
470 |
0.68 |
chr2_31483571_31483901 | 2.12 |
Ass1 |
argininosuccinate synthetase 1 |
13529 |
0.18 |
chr8_35383605_35384049 | 2.12 |
Ppp1r3b |
protein phosphatase 1, regulatory subunit 3B |
7167 |
0.17 |
chr11_106841855_106842078 | 2.12 |
Smurf2 |
SMAD specific E3 ubiquitin protein ligase 2 |
2668 |
0.18 |
chr9_60982764_60983106 | 2.11 |
Gm5122 |
predicted gene 5122 |
30546 |
0.14 |
chr19_40165767_40165918 | 2.11 |
Cyp2c70 |
cytochrome P450, family 2, subfamily c, polypeptide 70 |
21444 |
0.14 |
chr1_39433880_39434250 | 2.11 |
Gm37265 |
predicted gene, 37265 |
14133 |
0.16 |
chr15_99038783_99039270 | 2.11 |
Tuba1c |
tubulin, alpha 1C |
8705 |
0.09 |
chr3_51185131_51185304 | 2.11 |
Noct |
nocturnin |
39230 |
0.12 |
chr10_68108745_68108896 | 2.11 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
27806 |
0.19 |
chr19_44394314_44394509 | 2.11 |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
12279 |
0.14 |
chr5_49060180_49060366 | 2.10 |
Gm43047 |
predicted gene 43047 |
9730 |
0.1 |
chr2_31493953_31494151 | 2.09 |
Ass1 |
argininosuccinate synthetase 1 |
3720 |
0.22 |
chr6_122819078_122819314 | 2.09 |
Foxj2 |
forkhead box J2 |
718 |
0.44 |
chr11_8523561_8523765 | 2.09 |
Tns3 |
tensin 3 |
21688 |
0.27 |
chr9_106234042_106234256 | 2.09 |
Alas1 |
aminolevulinic acid synthase 1 |
2935 |
0.14 |
chr7_97414019_97414355 | 2.09 |
Thrsp |
thyroid hormone responsive |
3332 |
0.16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.9 | 17.6 | GO:0010046 | response to mycotoxin(GO:0010046) |
4.8 | 14.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
4.1 | 12.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
3.1 | 15.7 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
2.9 | 11.4 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
2.7 | 10.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
2.7 | 10.8 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
2.5 | 9.8 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
2.3 | 4.7 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
2.3 | 4.6 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
2.3 | 6.8 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
2.2 | 6.5 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.7 | 5.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.5 | 7.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.5 | 1.5 | GO:0006106 | fumarate metabolic process(GO:0006106) |
1.4 | 5.7 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
1.4 | 4.2 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.3 | 6.3 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
1.2 | 3.7 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
1.2 | 3.6 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
1.2 | 7.2 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
1.1 | 12.5 | GO:0009404 | toxin metabolic process(GO:0009404) |
1.1 | 4.6 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.1 | 5.6 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.1 | 1.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.1 | 3.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
1.1 | 2.1 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
1.0 | 4.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
1.0 | 4.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
1.0 | 3.1 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.0 | 4.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.0 | 3.0 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
1.0 | 3.0 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
1.0 | 5.8 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.9 | 4.7 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.9 | 0.9 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.9 | 3.7 | GO:0003383 | apical constriction(GO:0003383) |
0.9 | 2.8 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.9 | 3.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.9 | 2.7 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.9 | 1.8 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.9 | 5.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.9 | 2.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.9 | 4.3 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.9 | 1.7 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.8 | 1.7 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.8 | 4.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.8 | 4.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.8 | 4.0 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.8 | 4.0 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.8 | 1.6 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.8 | 3.9 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.8 | 1.6 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.8 | 0.8 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.8 | 0.8 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.8 | 5.3 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.7 | 0.7 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
0.7 | 2.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.7 | 2.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.7 | 2.9 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.7 | 2.9 | GO:0018214 | protein carboxylation(GO:0018214) |
0.7 | 0.7 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.7 | 0.7 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.7 | 2.2 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.7 | 1.4 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.7 | 3.6 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.7 | 2.1 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.7 | 2.1 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.7 | 2.1 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.7 | 2.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.7 | 4.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.7 | 2.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.7 | 13.7 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.7 | 2.0 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.7 | 2.0 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.7 | 2.0 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.7 | 2.6 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
0.7 | 2.6 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.7 | 2.0 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.6 | 7.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.6 | 1.9 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.6 | 1.9 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.6 | 0.6 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.6 | 1.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.6 | 2.5 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.6 | 1.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.6 | 0.6 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.6 | 1.8 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.6 | 1.8 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.6 | 1.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.6 | 0.6 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.6 | 1.8 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
0.6 | 1.2 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.6 | 2.4 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.6 | 2.3 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.6 | 5.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.6 | 1.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.6 | 1.7 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.6 | 1.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.6 | 1.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.6 | 1.1 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.6 | 2.2 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.6 | 1.1 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.5 | 4.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.5 | 2.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.5 | 2.7 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.5 | 3.2 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.5 | 1.6 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.5 | 0.5 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.5 | 1.6 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.5 | 2.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.5 | 1.6 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.5 | 0.5 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.5 | 3.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.5 | 1.0 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.5 | 1.5 | GO:0006562 | proline catabolic process(GO:0006562) |
0.5 | 1.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.5 | 0.5 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.5 | 2.0 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.5 | 0.5 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.5 | 1.5 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.5 | 1.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.5 | 1.5 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.5 | 0.5 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.5 | 1.5 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.5 | 3.9 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.5 | 1.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.5 | 3.9 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.5 | 2.4 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.5 | 1.4 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.5 | 3.4 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.5 | 1.4 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.5 | 2.9 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.5 | 1.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.5 | 2.8 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.5 | 3.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.5 | 1.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.5 | 0.5 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.5 | 2.3 | GO:0046618 | drug export(GO:0046618) |
0.5 | 0.9 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.5 | 0.5 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.5 | 1.8 | GO:0035627 | ceramide transport(GO:0035627) |
0.5 | 0.9 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.5 | 0.9 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.5 | 2.7 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.4 | 5.4 | GO:0010225 | response to UV-C(GO:0010225) |
0.4 | 0.4 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.4 | 3.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.4 | 3.6 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.4 | 1.8 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.4 | 1.8 | GO:1903798 | regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
0.4 | 0.4 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.4 | 8.0 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.4 | 2.6 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.4 | 0.9 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.4 | 1.3 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.4 | 1.7 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.4 | 1.7 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.4 | 1.7 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.4 | 0.9 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.4 | 2.6 | GO:0015871 | choline transport(GO:0015871) |
0.4 | 1.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.4 | 2.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.4 | 1.3 | GO:0035973 | aggrephagy(GO:0035973) |
0.4 | 1.3 | GO:0090427 | activation of meiosis(GO:0090427) |
0.4 | 1.7 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.4 | 0.8 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.4 | 1.2 | GO:0030070 | insulin processing(GO:0030070) |
0.4 | 1.2 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.4 | 0.8 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.4 | 1.2 | GO:0019230 | proprioception(GO:0019230) |
0.4 | 4.1 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.4 | 1.6 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.4 | 0.4 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.4 | 0.8 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.4 | 4.0 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.4 | 1.6 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.4 | 0.8 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.4 | 0.8 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.4 | 1.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.4 | 0.8 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.4 | 1.2 | GO:0006573 | valine metabolic process(GO:0006573) |
0.4 | 2.0 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.4 | 0.8 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.4 | 0.8 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.4 | 0.8 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.4 | 0.4 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.4 | 1.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 2.7 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.4 | 2.3 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.4 | 1.1 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.4 | 2.7 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.4 | 1.9 | GO:0006477 | protein sulfation(GO:0006477) |
0.4 | 3.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.4 | 2.3 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.4 | 3.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.4 | 0.7 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.4 | 1.5 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.4 | 1.1 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.4 | 2.6 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.4 | 1.1 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.4 | 1.1 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.4 | 2.9 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.4 | 2.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.4 | 0.7 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.4 | 1.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.4 | 1.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.4 | 1.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.4 | 1.4 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.4 | 0.7 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.4 | 1.4 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.4 | 1.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.4 | 3.9 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.4 | 0.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.4 | 0.4 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.4 | 1.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.4 | 1.8 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.4 | 4.9 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.3 | 2.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 1.7 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.3 | 1.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.3 | 0.3 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.3 | 3.8 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.3 | 0.7 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.3 | 1.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 12.0 | GO:0007584 | response to nutrient(GO:0007584) |
0.3 | 3.8 | GO:0017144 | drug metabolic process(GO:0017144) |
0.3 | 0.3 | GO:0019401 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
0.3 | 1.7 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.3 | 1.0 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.3 | 1.0 | GO:0010288 | response to lead ion(GO:0010288) |
0.3 | 0.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 0.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.3 | 1.7 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.3 | 1.3 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.3 | 0.3 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.3 | 0.7 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.3 | 1.0 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.3 | 0.7 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.3 | 1.3 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.3 | 1.0 | GO:0008355 | olfactory learning(GO:0008355) |
0.3 | 1.3 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.3 | 1.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.3 | 0.6 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.3 | 1.0 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.3 | 1.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 0.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 0.6 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.3 | 1.0 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.3 | 2.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 0.6 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.3 | 0.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.3 | 1.3 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.3 | 1.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 1.6 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.3 | 0.6 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.3 | 0.6 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.3 | 0.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.3 | 2.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.3 | 0.3 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.3 | 0.9 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.3 | 0.9 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.3 | 0.9 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.3 | 0.9 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.3 | 1.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.3 | 1.2 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.3 | 1.8 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 0.9 | GO:0061010 | gall bladder development(GO:0061010) |
0.3 | 0.3 | GO:0061724 | lipophagy(GO:0061724) |
0.3 | 0.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.3 | 0.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 4.5 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.3 | 0.3 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
0.3 | 1.5 | GO:0098597 | observational learning(GO:0098597) |
0.3 | 1.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.3 | 0.6 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.3 | 1.8 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 1.2 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.3 | 5.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.3 | 0.9 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.3 | 1.7 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.3 | 2.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.3 | 2.0 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.3 | 2.3 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.3 | 0.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.3 | 0.6 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.3 | 0.3 | GO:0071047 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.3 | 0.8 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.3 | 1.4 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.3 | 1.7 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.3 | 3.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 6.2 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.3 | 0.6 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.3 | 1.1 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
0.3 | 1.9 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.3 | 1.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.3 | 0.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.3 | 0.6 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 1.4 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.3 | 0.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.3 | 0.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 0.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.3 | 1.6 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.3 | 0.5 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.3 | 0.8 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.3 | 0.3 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.3 | 1.6 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.3 | 1.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.3 | 0.5 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.3 | 0.3 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.3 | 0.5 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.3 | 1.1 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.3 | 0.8 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.3 | 0.8 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.3 | 0.8 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.3 | 0.8 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.3 | 2.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 0.8 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.3 | 1.8 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.3 | 1.0 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.3 | 0.8 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.3 | 1.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.3 | 2.0 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.3 | 1.0 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.3 | 0.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 0.5 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.3 | 0.5 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.3 | 0.5 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.3 | 2.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 0.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 0.5 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.2 | 1.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 1.0 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 0.5 | GO:1903969 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.2 | 1.5 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.2 | 0.7 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.2 | 0.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 0.5 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.2 | 0.5 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.2 | 0.7 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 0.5 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.2 | 0.7 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 0.7 | GO:0035360 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.2 | 0.5 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 0.2 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.2 | 1.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 0.7 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.2 | 0.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 0.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.2 | 0.2 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.2 | 1.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.7 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.9 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.2 | 2.6 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.2 | 0.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 1.9 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.2 | 2.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 0.9 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 0.5 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.2 | 2.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 1.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 2.1 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 0.2 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.2 | 0.7 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.2 | 0.5 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
0.2 | 2.5 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.5 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.2 | 0.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.2 | 0.5 | GO:0048382 | mesendoderm development(GO:0048382) |
0.2 | 0.9 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.2 | 0.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 1.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.2 | 1.3 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.2 | 0.2 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.2 | 0.7 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.2 | 1.8 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 0.4 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 0.4 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 0.9 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 0.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.7 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.2 | 0.7 | GO:0019627 | urea metabolic process(GO:0019627) |
0.2 | 0.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 1.1 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.2 | 0.7 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.2 | 0.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 1.7 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 0.7 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.2 | 4.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 1.5 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 0.2 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.2 | 1.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.2 | 0.6 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 1.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 1.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 1.3 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.2 | 0.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 0.9 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.2 | 0.6 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.2 | 0.4 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.2 | 1.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.2 | 0.4 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.2 | 0.6 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.2 | 1.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 0.2 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.2 | 1.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 1.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 1.5 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 0.8 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.2 | 0.4 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.2 | 0.2 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 0.2 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 5.1 | GO:0060325 | face morphogenesis(GO:0060325) |
0.2 | 2.5 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.2 | 0.6 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.2 | 0.2 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.2 | 1.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.6 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.2 | 0.4 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.2 | 0.4 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.2 | 0.6 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.6 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.2 | 0.6 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 1.4 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 1.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 1.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.2 | 0.6 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.2 | 2.0 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.2 | 1.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.2 | 0.6 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 3.0 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 1.4 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 1.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.2 | 0.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.2 | 1.4 | GO:0045176 | apical protein localization(GO:0045176) |
0.2 | 3.0 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.2 | 0.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 1.8 | GO:0006241 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.2 | 1.2 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.2 | 0.8 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 1.8 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 0.4 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.2 | 1.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.6 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.6 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 0.6 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.2 | 5.6 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.2 | 0.4 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 0.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 8.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.6 | GO:0045297 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.2 | 0.6 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.2 | 1.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 0.6 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.2 | 0.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 3.9 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.2 | 0.2 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.6 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.2 | 0.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.4 | GO:0030952 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.2 | 1.7 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.2 | 1.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.7 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.2 | 0.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.2 | 0.7 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.2 | 0.9 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.2 | 0.7 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.2 | 1.7 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.2 | 0.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 0.7 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.2 | 1.3 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.2 | 0.5 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.2 | 0.4 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.2 | 0.7 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.2 | 0.4 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 1.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.2 | 0.9 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 0.5 | GO:1903726 | negative regulation of phospholipid biosynthetic process(GO:0071072) negative regulation of phospholipid metabolic process(GO:1903726) |
0.2 | 0.4 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.2 | 0.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 2.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 1.1 | GO:0006903 | vesicle targeting(GO:0006903) |
0.2 | 0.4 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.2 | 0.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 1.6 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 0.4 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.2 | 0.4 | GO:0015695 | organic cation transport(GO:0015695) |
0.2 | 2.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 1.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 0.5 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.2 | 0.4 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.2 | 0.4 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
0.2 | 0.9 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 1.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.2 | 0.5 | GO:0008354 | germ cell migration(GO:0008354) |
0.2 | 0.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 0.2 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.2 | 1.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.2 | 0.7 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.2 | 3.0 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.2 | 0.3 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.2 | 1.2 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.2 | 0.7 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
0.2 | 0.3 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.2 | 0.2 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.2 | 0.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.5 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.2 | 0.3 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.2 | 0.3 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.2 | 0.2 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.2 | 1.4 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.2 | 1.0 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
0.2 | 1.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 2.2 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.2 | 0.5 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 0.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.2 | 1.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 0.2 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.2 | 0.2 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.2 | 0.7 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.2 | 0.8 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.2 | 0.3 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.2 | 0.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 0.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.2 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.2 | 2.8 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 2.8 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 0.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 1.0 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 0.5 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 0.5 | GO:0000087 | mitotic M phase(GO:0000087) |
0.2 | 0.5 | GO:0043366 | beta selection(GO:0043366) |
0.2 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 0.3 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 0.6 | GO:0006057 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.2 | 0.5 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.2 | 0.3 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.2 | 0.2 | GO:0022605 | oogenesis stage(GO:0022605) |
0.2 | 2.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 0.6 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.2 | 0.3 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.2 | 0.3 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.2 | 0.3 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) regulation of respiratory system process(GO:0044065) |
0.2 | 0.6 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 0.5 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.2 | 0.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 0.2 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.2 | 0.2 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 0.6 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 4.3 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.2 | 0.3 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.2 | 0.5 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 0.8 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 2.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 2.6 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.2 | 0.8 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.2 | 0.2 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.2 | 1.4 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.2 | 0.6 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.2 | 0.6 | GO:0070266 | necroptotic process(GO:0070266) |
0.2 | 0.9 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.2 | 1.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 0.6 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 0.3 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 0.2 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.2 | 0.5 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.2 | 1.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 2.3 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.4 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 2.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 1.5 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.4 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.3 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 0.3 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.3 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.1 | 2.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.7 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 1.8 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.4 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 0.7 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.6 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 0.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 3.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 2.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.4 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.1 | 0.9 | GO:0071025 | RNA surveillance(GO:0071025) |
0.1 | 0.1 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.1 | 0.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.4 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.1 | 0.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.6 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.1 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.1 | 0.3 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.1 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.9 | GO:0097286 | iron ion import(GO:0097286) |
0.1 | 0.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.3 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 2.4 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.1 | 0.6 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.1 | 0.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.4 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.3 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.1 | 4.9 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 1.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.3 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.1 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 0.7 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.3 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 0.1 | GO:0030035 | microspike assembly(GO:0030035) |
0.1 | 0.7 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.1 | 0.4 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.1 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 1.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.1 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.1 | 2.9 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 5.9 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.1 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
0.1 | 0.4 | GO:0060406 | regulation of penile erection(GO:0060405) positive regulation of penile erection(GO:0060406) |
0.1 | 0.1 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.1 | 0.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.1 | 0.3 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 0.4 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.1 | 0.8 | GO:0061037 | negative regulation of chondrocyte differentiation(GO:0032331) negative regulation of cartilage development(GO:0061037) |
0.1 | 1.9 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.7 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 0.3 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.1 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.1 | 0.5 | GO:0070203 | regulation of establishment of protein localization to chromosome(GO:0070202) regulation of establishment of protein localization to telomere(GO:0070203) |
0.1 | 0.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.5 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.1 | 1.5 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 0.4 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.7 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.1 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.1 | 0.4 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.8 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.1 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.3 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.8 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.4 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.1 | 2.8 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.5 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 1.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.1 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.1 | 0.3 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.1 | 1.0 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.1 | 1.2 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.7 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.3 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.3 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.4 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.1 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.1 | 0.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.1 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
0.1 | 0.3 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.1 | 0.3 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 0.3 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.1 | 0.1 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.1 | GO:0035090 | maintenance of cell polarity(GO:0030011) maintenance of apical/basal cell polarity(GO:0035090) |
0.1 | 0.5 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.8 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.3 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.3 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) negative regulation of mast cell apoptotic process(GO:0033026) |
0.1 | 0.2 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
0.1 | 0.2 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 0.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 1.1 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.1 | 1.0 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.1 | 0.5 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.4 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.6 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.4 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.1 | 0.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.5 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.1 | 0.2 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.1 | 0.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.4 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.1 | 0.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.2 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.1 | 0.7 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.1 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.2 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.6 | GO:0010820 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
0.1 | 0.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.5 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.1 | 0.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.2 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.5 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.1 | 0.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 0.6 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.1 | 0.1 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.1 | 0.1 | GO:0015810 | aspartate transport(GO:0015810) |
0.1 | 0.2 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.1 | 0.5 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.1 | 0.3 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.1 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.1 | GO:0035739 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) |
0.1 | 0.7 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.1 | 0.1 | GO:0014889 | muscle atrophy(GO:0014889) |
0.1 | 1.7 | GO:0098586 | cellular response to virus(GO:0098586) |
0.1 | 0.5 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.1 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.7 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.1 | 0.2 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 1.3 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.1 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 2.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.2 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.1 | 2.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 1.6 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.1 | 0.4 | GO:0042026 | protein refolding(GO:0042026) |
0.1 | 0.4 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.5 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.6 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.4 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.2 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 1.6 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.6 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 0.1 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.1 | 0.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.2 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.1 | 0.7 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 1.8 | GO:0048536 | spleen development(GO:0048536) |
0.1 | 0.1 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.1 | 0.7 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 0.5 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 0.6 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.2 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.1 | 0.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.5 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 0.4 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 0.1 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.1 | 0.3 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.3 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 3.4 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.1 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 1.0 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.2 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.1 | 1.4 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.8 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 1.4 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.1 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.8 | GO:1901032 | negative regulation of response to reactive oxygen species(GO:1901032) |
0.1 | 0.1 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.1 | 2.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.3 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.1 | 0.5 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.3 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.5 | GO:0030852 | regulation of granulocyte differentiation(GO:0030852) |
0.1 | 0.2 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.1 | 2.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.9 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 1.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.1 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.1 | 0.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 0.5 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.1 | 0.2 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.4 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 3.0 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.1 | 0.2 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.1 | 0.5 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.3 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.4 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.6 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.3 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.1 | 0.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.5 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.4 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.1 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.1 | 0.5 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.1 | 0.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.2 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 0.3 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.1 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.1 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.1 | 0.3 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 2.1 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.3 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 1.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.1 | 1.1 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.1 | 0.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.1 | 0.3 | GO:0061440 | renal system vasculature development(GO:0061437) kidney vasculature development(GO:0061440) |
0.1 | 0.2 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.1 | 0.6 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.3 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 0.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.4 | GO:0009145 | ATP biosynthetic process(GO:0006754) purine nucleoside triphosphate biosynthetic process(GO:0009145) purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
0.1 | 1.0 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 0.8 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.2 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.1 | 0.1 | GO:2000041 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.1 | 0.4 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 1.1 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.2 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.1 | 0.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.8 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.2 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.1 | 0.6 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.1 | 0.3 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.8 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.2 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.1 | 0.2 | GO:0090185 | negative regulation of mesonephros development(GO:0061218) negative regulation of kidney development(GO:0090185) |
0.1 | 0.1 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.1 | 0.2 | GO:0015872 | dopamine transport(GO:0015872) |
0.1 | 0.2 | GO:0043144 | snoRNA processing(GO:0043144) |
0.1 | 0.1 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.1 | 0.1 | GO:0052330 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
0.1 | 0.5 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.3 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.1 | GO:0051135 | positive regulation of NK T cell activation(GO:0051135) |
0.1 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 1.1 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 2.2 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.2 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.1 | 0.4 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.1 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 1.8 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.1 | 0.2 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.1 | 2.2 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 1.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 1.2 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 2.4 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 2.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.1 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.1 | 0.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.1 | GO:0046959 | habituation(GO:0046959) |
0.1 | 0.1 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.1 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 0.2 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.5 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.3 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.6 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.1 | 0.3 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.3 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.1 | 0.4 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.1 | 0.7 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.2 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.1 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.1 | 0.1 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
0.1 | 0.3 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.9 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.3 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.4 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.2 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 2.1 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.5 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.5 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.1 | 0.3 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.3 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
0.1 | 0.2 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.6 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 0.3 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 1.4 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 1.3 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.4 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.1 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.1 | 0.8 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.1 | 0.4 | GO:0060324 | face development(GO:0060324) |
0.1 | 0.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.3 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.2 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.1 | 0.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.3 | GO:0052204 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.2 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.2 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 0.5 | GO:0002931 | response to ischemia(GO:0002931) |
0.1 | 0.1 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.1 | GO:0060066 | oviduct development(GO:0060066) |
0.1 | 0.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.7 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) endochondral bone morphogenesis(GO:0060350) |
0.1 | 0.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.4 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
0.1 | 0.1 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.1 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.5 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 0.1 | GO:1903205 | regulation of hydrogen peroxide-induced cell death(GO:1903205) |
0.1 | 0.5 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.2 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.1 | 0.2 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.1 | 2.6 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.1 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.1 | 0.1 | GO:0090135 | actin filament branching(GO:0090135) |
0.1 | 0.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 2.0 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.1 | 0.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.1 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.1 | 2.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.3 | GO:0042711 | maternal behavior(GO:0042711) |
0.1 | 0.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.1 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.1 | 0.1 | GO:0009584 | detection of visible light(GO:0009584) |
0.1 | 0.5 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.2 | GO:1900271 | regulation of long-term synaptic potentiation(GO:1900271) |
0.1 | 0.4 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.6 | GO:1904377 | positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 0.1 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.1 | 0.2 | GO:0034311 | diol metabolic process(GO:0034311) |
0.1 | 0.5 | GO:0007625 | grooming behavior(GO:0007625) |
0.1 | 0.6 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.1 | 0.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.7 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.1 | GO:0019478 | D-amino acid catabolic process(GO:0019478) D-amino acid metabolic process(GO:0046416) |
0.1 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.7 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.7 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.4 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.1 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.1 | 0.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.3 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.2 | GO:0042701 | progesterone secretion(GO:0042701) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.6 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.2 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.1 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.1 | 0.1 | GO:0060746 | parental behavior(GO:0060746) |
0.1 | 0.1 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.1 | 0.1 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.1 | 0.1 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.1 | 0.6 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.1 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.1 | GO:0071374 | response to parathyroid hormone(GO:0071107) cellular response to parathyroid hormone stimulus(GO:0071374) |
0.0 | 0.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.0 | 0.3 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.2 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.3 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.0 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.0 | 0.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.4 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.2 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.0 | 0.0 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.0 | 0.2 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.1 | GO:0048538 | thymus development(GO:0048538) |
0.0 | 0.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.3 | GO:0009299 | mRNA transcription(GO:0009299) |
0.0 | 0.1 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.6 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.2 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.1 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.0 | 0.5 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.1 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.0 | 0.0 | GO:0090153 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) |
0.0 | 0.4 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 0.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.2 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.0 | 0.4 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.1 | GO:0061450 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
0.0 | 0.0 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.0 | 0.4 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.0 | 0.0 | GO:0035106 | operant conditioning(GO:0035106) |
0.0 | 0.1 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.0 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.0 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.0 | 0.0 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.3 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.1 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.0 | 1.1 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 1.1 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.0 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.9 | GO:0016575 | histone deacetylation(GO:0016575) |
0.0 | 0.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.0 | 0.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.1 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.0 | 0.2 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.0 | 0.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.2 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.0 | 0.5 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.1 | GO:2000406 | positive regulation of T cell migration(GO:2000406) |
0.0 | 0.0 | GO:0051503 | purine nucleotide transport(GO:0015865) adenine nucleotide transport(GO:0051503) |
0.0 | 0.1 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.0 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.3 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.5 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 0.4 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.0 | 0.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.0 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.0 | 0.0 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.0 | 0.0 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:0003266 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.0 | 0.2 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.0 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.3 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.0 | 0.4 | GO:0030431 | sleep(GO:0030431) |
0.0 | 0.3 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.1 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.3 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 0.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.2 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.1 | GO:0033572 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.2 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.6 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.0 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.0 | 0.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.0 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 0.0 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.0 | 0.0 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.1 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.0 | 0.6 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.0 | 0.0 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.0 | 0.0 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.0 | 0.1 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.0 | 0.1 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.0 | 0.0 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.0 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.0 | 0.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.1 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.0 | 0.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.1 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.0 | 0.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.0 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.0 | 0.5 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.2 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 2.3 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.0 | 0.4 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 1.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.9 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.1 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.0 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.0 | 0.1 | GO:0043586 | tongue development(GO:0043586) |
0.0 | 0.0 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.0 | GO:0060438 | trachea development(GO:0060438) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.0 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.0 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.0 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.1 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.0 | 0.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.0 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.0 | 0.1 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.0 | 0.0 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.0 | 0.1 | GO:0048806 | genitalia development(GO:0048806) |
0.0 | 0.0 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.0 | 0.0 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.0 | GO:0032264 | IMP salvage(GO:0032264) |
0.0 | 0.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.0 | GO:0036394 | amylase secretion(GO:0036394) |
0.0 | 0.0 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.0 | 0.0 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.0 | 0.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.2 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 0.0 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) |
0.0 | 0.1 | GO:0071435 | potassium ion export(GO:0071435) |
0.0 | 0.0 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.0 | 0.0 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.3 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 0.0 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.1 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.1 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.0 | 0.2 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.1 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.0 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.0 | GO:0007620 | copulation(GO:0007620) |
0.0 | 0.0 | GO:0051255 | mitotic spindle elongation(GO:0000022) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.0 | GO:0009301 | snRNA transcription(GO:0009301) |
0.0 | 0.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.1 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.0 | 0.0 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.9 | GO:0006818 | hydrogen transport(GO:0006818) |
0.0 | 0.0 | GO:0050904 | diapedesis(GO:0050904) |
0.0 | 0.4 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.0 | 0.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.0 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.2 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.0 | 0.0 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.1 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.0 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.0 | 0.0 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.0 | 0.2 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.0 | 0.0 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.0 | 0.0 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 1.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.0 | 0.0 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.0 | 0.0 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.0 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.1 | GO:0032329 | L-serine transport(GO:0015825) serine transport(GO:0032329) |
0.0 | 0.0 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.0 | 0.0 | GO:0044351 | macropinocytosis(GO:0044351) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 11.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
2.0 | 21.6 | GO:0070852 | cell body fiber(GO:0070852) |
1.6 | 4.8 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.3 | 6.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.3 | 8.9 | GO:0045180 | basal cortex(GO:0045180) |
1.2 | 5.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.2 | 4.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.0 | 4.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.9 | 7.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.9 | 3.4 | GO:0071203 | WASH complex(GO:0071203) |
0.8 | 4.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.8 | 2.4 | GO:0097441 | basilar dendrite(GO:0097441) |
0.8 | 3.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.7 | 2.9 | GO:0032021 | NELF complex(GO:0032021) |
0.7 | 2.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.7 | 2.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.7 | 2.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.6 | 3.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.6 | 1.8 | GO:0097413 | Lewy body(GO:0097413) |
0.6 | 0.6 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.6 | 2.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.6 | 1.7 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.6 | 1.7 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.5 | 1.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.5 | 1.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.5 | 2.9 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 5.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.5 | 1.8 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.5 | 1.8 | GO:0070545 | PeBoW complex(GO:0070545) |
0.5 | 1.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.4 | 2.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 6.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.4 | 2.9 | GO:0016342 | catenin complex(GO:0016342) |
0.4 | 4.9 | GO:0031528 | microvillus membrane(GO:0031528) |
0.4 | 1.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.4 | 4.0 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.4 | 1.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 1.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.4 | 0.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.4 | 1.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.4 | 1.9 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.4 | 0.4 | GO:0097342 | ripoptosome(GO:0097342) |
0.4 | 1.8 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.4 | 4.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 4.8 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.4 | 1.5 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.4 | 1.1 | GO:0071942 | XPC complex(GO:0071942) |
0.4 | 2.5 | GO:0032009 | early phagosome(GO:0032009) |
0.3 | 1.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.3 | 3.7 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 2.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 2.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.3 | 0.3 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 1.9 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.3 | 1.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.3 | 0.6 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.3 | 0.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.3 | 3.6 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 1.8 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.3 | 1.5 | GO:0089701 | U2AF(GO:0089701) |
0.3 | 1.5 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.3 | 13.4 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.3 | 1.2 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.3 | 16.9 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 2.0 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.3 | 11.4 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.3 | 0.6 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 1.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.3 | 2.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 1.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 0.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 0.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 1.9 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 8.9 | GO:0031672 | A band(GO:0031672) |
0.3 | 1.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.3 | 1.0 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.3 | 0.8 | GO:0055087 | Ski complex(GO:0055087) |
0.3 | 2.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 0.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 0.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 0.7 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 0.7 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 2.7 | GO:0030120 | vesicle coat(GO:0030120) |
0.2 | 4.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 2.9 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 0.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 2.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 2.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 0.7 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 0.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 2.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 1.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 1.6 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.2 | 2.6 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 1.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 0.9 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.2 | 0.7 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.2 | 0.5 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.2 | 1.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 0.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 0.2 | GO:0005818 | aster(GO:0005818) |
0.2 | 3.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 1.3 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 0.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 1.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.2 | 2.8 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 0.2 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 1.2 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 1.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 1.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 1.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 3.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 3.2 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 0.8 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 1.5 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 0.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 0.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 3.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 0.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 0.2 | GO:0044308 | axonal spine(GO:0044308) |
0.2 | 2.2 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.2 | 3.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 1.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 0.7 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 1.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 0.9 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 0.5 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 1.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 0.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 0.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.2 | 2.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 2.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 1.0 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 0.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 15.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.2 | 0.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 0.9 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 27.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 0.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 1.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 0.3 | GO:0043256 | laminin complex(GO:0043256) |
0.2 | 0.7 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 0.8 | GO:1990752 | microtubule end(GO:1990752) |
0.2 | 1.0 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 0.3 | GO:0097513 | myosin II filament(GO:0097513) |
0.2 | 0.6 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.2 | 0.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 0.8 | GO:0036128 | CatSper complex(GO:0036128) |
0.2 | 0.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 0.8 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.2 | 2.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 0.9 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 0.9 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 0.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 0.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.2 | 0.5 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.2 | 0.6 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 0.5 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.2 | 1.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 1.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 1.1 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.2 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 1.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 0.6 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.2 | 5.4 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 1.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.1 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 2.7 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 7.0 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 0.6 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.6 | GO:0001652 | granular component(GO:0001652) |
0.1 | 1.3 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 0.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 2.3 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.1 | 1.0 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 1.6 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 11.3 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.4 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 2.7 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 1.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.8 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 1.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.5 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 1.0 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.8 | GO:0001939 | female pronucleus(GO:0001939) |
0.1 | 0.1 | GO:0005594 | FACIT collagen trimer(GO:0005593) collagen type IX trimer(GO:0005594) |
0.1 | 0.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 4.3 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.1 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 2.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.5 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 9.5 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 1.0 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.1 | 0.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 1.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 1.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 1.0 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.7 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 1.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 13.3 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 1.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.8 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 3.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.8 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.4 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.6 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 1.7 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 1.4 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 1.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 6.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.5 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.4 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 1.1 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.1 | 3.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.5 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 0.1 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.1 | 1.3 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 1.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.4 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 1.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 1.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 3.2 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.5 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 17.5 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 0.1 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 1.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 1.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.6 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.6 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.4 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.1 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.1 | 0.8 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.1 | 0.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.4 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 0.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 5.2 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 1.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.3 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 6.3 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.7 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 1.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 1.5 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.5 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 4.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 19.4 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 1.3 | GO:0043034 | costamere(GO:0043034) |
0.1 | 2.4 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 1.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.5 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 0.2 | GO:1990777 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.1 | 66.1 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 1.0 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.1 | GO:0005819 | spindle(GO:0005819) |
0.1 | 1.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 1.4 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 1.1 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 2.2 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 0.8 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.6 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.9 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 1.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.8 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.2 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 1.1 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.8 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.4 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 2.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 2.8 | GO:0030016 | myofibril(GO:0030016) |
0.1 | 57.0 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 1.1 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 8.3 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 0.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.3 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 2.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.4 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 4.3 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 0.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 1.1 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.6 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 0.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.0 | GO:0043219 | lateral loop(GO:0043219) |
0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.2 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 4.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.0 | GO:0002177 | manchette(GO:0002177) |
0.0 | 1.6 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.1 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.0 | 7.9 | GO:0005912 | adherens junction(GO:0005912) |
0.0 | 0.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 1.1 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 1.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 3.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 11.5 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 12.7 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.2 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 2.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.1 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.2 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.0 | 0.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 1.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 2.1 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 1.2 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.2 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 1.0 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.9 | GO:0034703 | cation channel complex(GO:0034703) |
0.0 | 0.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.2 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.7 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 0.0 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 47.6 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.0 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.0 | GO:0031209 | SCAR complex(GO:0031209) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
3.8 | 11.5 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
3.6 | 10.7 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
2.7 | 8.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
2.5 | 9.8 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
2.3 | 13.6 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
2.0 | 5.9 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.9 | 5.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.9 | 5.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.5 | 4.5 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.4 | 4.2 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.3 | 4.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.3 | 17.3 | GO:0015643 | toxic substance binding(GO:0015643) |
1.3 | 5.3 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.3 | 9.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.2 | 3.6 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.1 | 3.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.1 | 9.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.0 | 3.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.0 | 5.2 | GO:0070728 | leucine binding(GO:0070728) |
1.0 | 2.1 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
1.0 | 2.9 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.9 | 2.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.9 | 2.6 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.9 | 1.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.9 | 2.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.8 | 4.2 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.8 | 4.2 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.8 | 11.8 | GO:0070402 | NADPH binding(GO:0070402) |
0.8 | 0.8 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.8 | 2.5 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.8 | 0.8 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.8 | 3.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.8 | 2.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.8 | 8.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.8 | 0.8 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.7 | 2.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.7 | 5.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.7 | 2.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.7 | 2.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.7 | 22.5 | GO:0052768 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.7 | 2.0 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.7 | 0.7 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.7 | 2.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.7 | 2.7 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.7 | 7.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.6 | 4.4 | GO:0034071 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.6 | 3.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.6 | 2.5 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.6 | 4.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.6 | 1.8 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.6 | 1.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.6 | 0.6 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
0.6 | 2.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.6 | 2.9 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.6 | 3.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.6 | 0.6 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.5 | 1.6 | GO:0004359 | glutaminase activity(GO:0004359) |
0.5 | 1.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.5 | 2.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.5 | 1.6 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.5 | 1.6 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.5 | 1.6 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.5 | 1.6 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.5 | 10.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.5 | 2.1 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.5 | 1.0 | GO:0070538 | oleic acid binding(GO:0070538) |
0.5 | 17.5 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.5 | 2.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.5 | 2.0 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.5 | 2.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.5 | 2.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.5 | 3.8 | GO:0035197 | siRNA binding(GO:0035197) |
0.5 | 2.8 | GO:0004064 | arylesterase activity(GO:0004064) |
0.5 | 2.8 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.5 | 9.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.5 | 1.4 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.4 | 1.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 1.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.4 | 4.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.4 | 1.8 | GO:0097001 | ceramide binding(GO:0097001) |
0.4 | 1.3 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.4 | 2.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.4 | 1.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 2.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.4 | 1.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.4 | 5.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.4 | 2.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.4 | 3.0 | GO:0046790 | virion binding(GO:0046790) |
0.4 | 2.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.4 | 3.3 | GO:0008430 | selenium binding(GO:0008430) |
0.4 | 1.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.4 | 8.6 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.4 | 1.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.4 | 1.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.4 | 1.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 1.2 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.4 | 1.2 | GO:0035671 | enone reductase activity(GO:0035671) |
0.4 | 3.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.4 | 1.5 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.4 | 2.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.4 | 3.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.4 | 6.5 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 1.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.4 | 1.1 | GO:0032551 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.4 | 1.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.4 | 1.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.4 | 2.6 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 1.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 0.7 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.4 | 1.1 | GO:0034893 | fluorene oxygenase activity(GO:0018585) mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.4 | 1.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.4 | 3.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.4 | 4.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.4 | 1.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.4 | 1.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.4 | 0.7 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.4 | 0.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 1.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.3 | 1.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.3 | 1.4 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 2.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.3 | 0.7 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.3 | 1.4 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.3 | 1.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 0.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 4.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 3.0 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.3 | 1.0 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.3 | 1.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 1.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.3 | 1.9 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.3 | 1.6 | GO:0016151 | nickel cation binding(GO:0016151) |
0.3 | 1.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.3 | 1.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 3.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.3 | 1.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.3 | 0.9 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.3 | 0.6 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 2.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.3 | 2.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.3 | 3.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 10.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.3 | 0.9 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 0.9 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.3 | 3.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 0.6 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.3 | 3.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 1.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 1.5 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.3 | 1.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 1.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 0.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.3 | 5.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 0.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 0.6 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 1.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.3 | 2.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 4.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 0.3 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.3 | 1.7 | GO:0048185 | activin binding(GO:0048185) |
0.3 | 0.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.3 | 0.8 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.3 | 2.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 1.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.3 | 3.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 1.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.3 | 3.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.3 | 1.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.3 | 1.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 0.3 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.3 | 2.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 5.1 | GO:0030552 | cAMP binding(GO:0030552) |
0.3 | 4.8 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 1.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 0.8 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.3 | 5.0 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.3 | 3.1 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 0.3 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.3 | 7.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 0.8 | GO:0019862 | IgA binding(GO:0019862) |
0.3 | 1.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 0.5 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.3 | 0.5 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.3 | 1.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 0.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 3.0 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 1.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.5 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 0.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 2.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 3.4 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.2 | 4.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 4.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 0.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 1.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 1.4 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 1.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 3.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 1.2 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.2 | 0.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.2 | 1.9 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.2 | 3.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 0.7 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 0.2 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) |
0.2 | 1.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 2.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 0.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.2 | 3.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 0.9 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 1.8 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 8.8 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.2 | 0.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 1.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 1.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 0.7 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 1.5 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 9.1 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.2 | 1.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 3.7 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.2 | 0.4 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.2 | 4.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.2 | 0.9 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 3.6 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 0.2 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.2 | 1.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 2.3 | GO:0050661 | NADP binding(GO:0050661) |
0.2 | 0.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 1.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 1.2 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.2 | 3.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 0.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 3.5 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.2 | 0.6 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 2.6 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 2.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 4.6 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.2 | 0.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 1.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 1.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 0.4 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 0.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 1.5 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.2 | 0.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 0.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 1.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.2 | 0.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 1.1 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 0.8 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 0.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.7 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 0.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 1.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 1.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 0.7 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 1.5 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.2 | 1.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.2 | 0.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 0.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 4.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 0.5 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 0.7 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 3.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 1.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.7 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.7 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 0.9 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 1.6 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 0.5 | GO:0005119 | smoothened binding(GO:0005119) |
0.2 | 0.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.2 | 0.7 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 0.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 0.5 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.2 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 3.6 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 0.9 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 0.7 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.5 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.2 | 0.3 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 0.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 0.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 0.5 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 0.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 0.5 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.2 | 1.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 2.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.8 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.2 | 0.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 0.5 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 0.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 0.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 0.8 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 1.6 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.2 | 1.8 | GO:0030371 | translation repressor activity(GO:0030371) |
0.2 | 0.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 2.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 0.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.2 | 0.9 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.2 | 0.2 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.2 | 0.8 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 0.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 0.8 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 0.6 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.2 | 0.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 1.7 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.2 | 0.9 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 0.5 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 0.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 1.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 1.3 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 1.2 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 1.0 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.7 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.3 | GO:0052849 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 1.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.7 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.7 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 2.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.9 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.6 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 1.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 1.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 2.0 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.4 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.1 | 0.7 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 2.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 4.6 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 1.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 1.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 1.2 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.8 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.8 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 3.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 4.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 10.6 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.4 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.6 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 2.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 1.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.6 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 0.4 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.4 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 1.1 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 4.1 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 0.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 2.6 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 1.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.7 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 1.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 1.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.4 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 2.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.6 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 1.5 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.7 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 0.4 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.5 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 0.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 1.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.4 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.1 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.2 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 0.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 1.6 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 0.8 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.1 | 0.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 2.9 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 2.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 2.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 1.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 1.1 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.7 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 1.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.3 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 0.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 1.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 9.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 7.3 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 2.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.6 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.5 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.8 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 14.5 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 0.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 2.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 1.0 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 1.0 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 1.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 1.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.2 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.1 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.1 | 0.9 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 1.0 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 0.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 1.7 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.6 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.1 | 0.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 1.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 3.6 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.3 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 0.1 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.1 | 0.1 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 1.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 6.4 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 1.1 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.1 | 0.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.7 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 3.9 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.4 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 2.1 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 3.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.3 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 1.0 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 2.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 1.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.5 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.2 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.3 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.5 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.1 | 0.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.6 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.2 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 1.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.7 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.2 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 0.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 0.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 1.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.4 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.1 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 1.0 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 2.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.7 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 1.9 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.2 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.1 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.1 | 0.1 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.1 | 0.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 1.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 1.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.5 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.3 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 0.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 1.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 1.4 | GO:0019707 | protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 1.2 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 0.9 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.1 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.2 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 1.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.4 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 10.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.7 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.1 | 0.3 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 0.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.1 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.1 | 1.3 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.4 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.1 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 42.4 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.2 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.7 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 0.6 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.4 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 1.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.1 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.1 | 1.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.1 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.1 | 0.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.6 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.4 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.0 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.0 | 0.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.2 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.0 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 0.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 1.9 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.0 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 2.5 | GO:0015108 | chloride transmembrane transporter activity(GO:0015108) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 8.8 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.6 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.4 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 1.2 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 1.1 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.0 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 1.3 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.0 | GO:0018555 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.0 | 2.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.0 | 0.4 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.0 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.3 | GO:0052715 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.0 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.8 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.2 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.1 | GO:0050543 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.0 | 5.3 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 0.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 1.0 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.0 | 0.2 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.0 | 0.2 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 1.3 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.5 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.3 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 2.2 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 1.1 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 6.3 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.1 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 0.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.0 | 0.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.0 | 0.0 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.0 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.8 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.2 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 0.0 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.0 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.0 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.0 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 2.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.2 | GO:0043176 | amine binding(GO:0043176) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.1 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.1 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 8.0 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.4 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.0 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.4 | GO:0044823 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 1.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 0.1 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 29.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.0 | 20.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.5 | 10.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 1.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.4 | 3.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 1.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.3 | 13.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 9.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 13.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 14.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 5.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 10.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.3 | 5.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 1.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 7.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 1.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 2.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 4.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 12.9 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 2.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 4.9 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 4.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 1.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 2.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 2.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 0.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 4.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 2.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 2.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 1.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 0.7 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 0.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 0.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 2.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 1.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 1.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.6 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 1.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 1.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 1.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 2.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.5 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 1.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 2.6 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 2.7 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 1.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 3.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 0.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 1.3 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 5.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 3.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 0.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 1.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 1.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.8 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 1.2 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 4.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.3 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 13.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.9 | 15.9 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.8 | 15.2 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.8 | 5.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.7 | 13.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.7 | 2.9 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.6 | 3.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.6 | 8.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.6 | 14.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.6 | 5.9 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.6 | 8.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.5 | 5.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.5 | 1.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.5 | 1.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.5 | 4.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.5 | 5.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.5 | 5.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.5 | 3.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.5 | 4.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.5 | 3.2 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.4 | 6.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.4 | 5.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.4 | 3.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 4.9 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.3 | 3.8 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.3 | 4.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 0.3 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.3 | 3.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 3.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 4.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.3 | 0.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 3.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 49.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.3 | 3.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 5.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 1.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.3 | 2.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 2.8 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.3 | 0.6 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 6.4 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.3 | 5.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.3 | 2.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.3 | 0.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.3 | 0.8 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.3 | 1.8 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 2.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 3.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 2.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 4.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 0.7 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.2 | 4.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 4.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 0.7 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.2 | 5.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 3.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 2.2 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.2 | 12.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.2 | 1.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 2.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 2.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 1.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 0.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 0.4 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.2 | 1.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 2.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 0.9 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.2 | 2.6 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 1.1 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.2 | 2.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 1.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 8.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 3.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 1.6 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.2 | 0.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.2 | 0.2 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.2 | 1.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.2 | 1.4 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.2 | 5.6 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.2 | 2.7 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 0.3 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.2 | 4.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 3.6 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.2 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 1.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 4.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.1 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.1 | 0.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 5.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 3.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 2.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 3.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 11.2 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 1.6 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 0.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 2.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 3.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 1.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 1.5 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.1 | 1.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.5 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 0.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 3.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 1.6 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.1 | 0.4 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |
0.1 | 2.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 1.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.3 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 1.6 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 1.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.5 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 0.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 0.3 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.1 | 1.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 5.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 1.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 2.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.4 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.1 | 0.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.3 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 3.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.1 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 0.7 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 1.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 1.2 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 1.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 0.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 3.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.8 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.1 | 1.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 7.3 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.1 | 0.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 1.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 1.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.6 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 4.7 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 0.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 0.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.2 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 1.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 3.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.1 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.1 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 1.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.4 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.7 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.0 | 0.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 0.2 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.0 | 0.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.2 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.0 | 1.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.1 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 0.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 3.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.2 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.0 | 0.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 1.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.2 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.1 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.0 | 0.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |